Nicotinic Agonists
Showing 1 - 25 of 707
Parkinson Disease, Mild Cognitive Impairment Trial in Stavanger (AZD0328, Placebo)
Withdrawn
- Parkinson Disease
- Mild Cognitive Impairment
- AZD0328
- Placebo
- (no location specified)
Oct 11, 2022
MDD, Substance Use Disorder, Normal Physiology Trial in Baltimore (Placebo Nicotine Patch, Nicotine Patch, Mecamylamine)
Recruiting
- Major Depressive Disorder
- +2 more
- Placebo Nicotine Patch
- +2 more
-
Baltimore, MarylandNational Institute on Drug Abuse
Sep 16, 2022
Depressive Disorder Trial in Nashville (Transdermal Nicotine Patch, Transdermal Placebo Patch)
Not yet recruiting
- Depressive Disorder
- Transdermal Nicotine Patch
- Transdermal Placebo Patch
-
Nashville, TennesseeVanderbilt Psychiatric Hosptial
Feb 14, 2023
Depressive Disorder Trial in Nashville (Transdermal Nicotine patch)
Not yet recruiting
- Depressive Disorder
- Transdermal Nicotine patch
-
Nashville, TennesseeVanderbilt Psychiatric Hospital
Feb 28, 2023
Vagus Nerve Stimulation Trial in Manhasset (Transcutaneous electrical auricular vagus nerve stimulation (VNS))
Terminated
- Vagus Nerve Stimulation
- Transcutaneous electrical auricular vagus nerve stimulation (VNS)
-
Manhasset, New YorkNorthwell Health
Dec 12, 2022
Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura
Not yet recruiting
- ITP - Immune Thrombocytopenia
- eltrombopag and romiplastim
- (no location specified)
Nov 16, 2023
Preoperative Prandial State of Patients Taking Glucagon-Like
Recruiting
- Pulmonary Aspiration
- Gastric ultrasound
-
Houston, TexasThe University of Texas Health Science Center at Houston
Jun 6, 2023
HIV Infection, Alcohol Use, Smoking Trial in St. Petersburg (Varenicline, Cytisine, Nicotine Replacement Therapy)
Completed
- HIV Infection
- +2 more
- Varenicline
- +5 more
-
St. Petersburg, Russian FederationFirst St. Petersburg Pavlov State Medical University
Dec 16, 2020
Delayed Gastric Emptying, Gastroparesis Trial in Chapel Hill (gastric ultrasound)
Not yet recruiting
- Delayed Gastric Emptying
- Gastroparesis
- gastric ultrasound
-
Chapel Hill, North CarolinaUniversity of North Carolina Medical Center
Sep 8, 2023
Glucagon-like Peptide-1 Receptor Agonists According to Type 2
Recruiting
- Diabetes Mellitus, Type 2
- GLP-1 receptor agonist
-
Bari, ItalyAzienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023
Exercise Performance Trial in Copenhagen (Vilanterol and Fluticasone Furoate, Indacaterol and Mometasone Furoate, Placebo)
Recruiting
- Exercise Performance
- Vilanterol and Fluticasone Furoate
- +2 more
-
Copenhagen, DenmarkAugust Krogh Building
Oct 4, 2023
Healthy Trial in Copenhagen (Exercise)
Withdrawn
- Healthy
- Exercise
-
Copenhagen, NV, DenmarkDepartment of Respiratory Medicine, L, Bispebjerg Hospital,
Feb 27, 2023
Migraine Prophylaxis Trial in Dhaka (Nicotinic Acid 500 MG Extended Release Oral Tablet, Nicotinic Acid 1000 MG Extended Release
Recruiting
- Migraine Prophylaxis
- Nicotinic Acid 500 MG Extended Release Oral Tablet
- +2 more
-
Dhaka, BangladeshBSMMU
May 5, 2023
Down Syndrome, Mild Cognitive Impairment Trial in Nashville (Low Dose Nicotine (7mg), Moderate Dose Nicotine (14mg))
Completed
- Down Syndrome
- Mild Cognitive Impairment
- Low Dose Nicotine (7mg)
- Moderate Dose Nicotine (14mg)
-
Nashville, TennesseeVanderbilt Psychiatric Hospital
May 6, 2022
Opioid-Induced Constipation Trial in Leuven (Naloxegol, codeine phosphate, Placebo)
Completed
- Opioid-Induced Constipation
- Naloxegol
- +2 more
-
Leuven, Vlaams-Brabant, BelgiumUZ Leuven
Mar 15, 2023
Alcohol Drinking Trial run by the NIAAA (Alcohol (Oral), Alcohol (IV), Alcohol (Ethanol))
Recruiting
- Alcohol Drinking
- Alcohol (Oral)
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 5, 2023
Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,
Recruiting
- Glaucoma, Suspect
- Aberration, Corneal Wavefront
- Low dosage selective alpha-2 receptor agonists topical eyedrop
- High dosage selective alpha-2 receptor agonists topical eyedrop
-
Banhā, QA, EgyptAhmed Abdelshafy
Jan 2, 2023
Uncontrolled Asthma Trial (Experimental: CHF6001 3200 µg, Placebo Comparator: CHF6001 Placebo)
Not yet recruiting
- Uncontrolled Asthma
- Experimental: CHF6001 3200 μg
- Placebo Comparator: CHF6001 Placebo
- (no location specified)
Sep 7, 2023
Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)
Not yet recruiting
- Morbid Obesity
- +4 more
- GLP-1 receptor agonist
-
Columbia, MissouriUniversity of Missouri Hospital
Nov 20, 2023
Healthy Aging Trial in Burlington (Nicotine patch, oral mecamylamine, )
Completed
- Healthy Aging
- Nicotine patch, oral mecamylamine, placebo
-
Burlington, VermontUniversity of Vermont
Mar 23, 2022
Human Immunodeficiency Virus, Smoking Cessation, Smoking, Cigarette Trial in Boston, Houston (QUIT, Time-Matched Control (TM))
Recruiting
- Human Immunodeficiency Virus
- +6 more
- QUIT
- Time-Matched Control (TM)
-
Boston, Massachusetts
- +2 more
Feb 1, 2021
Glucagon-like Peptide 1 Receptor Agonists and Mental Health
Not yet recruiting
- Diabetes Mellitus
- +2 more
- GLP-1 receptor agonist
- (no location specified)
Aug 4, 2022
Type 2 Diabetes Trial in Lancaster (Exenatide Injection, Saline injection)
Terminated
- Type 2 Diabetes
- Exenatide Injection
- Saline injection
-
Lancaster, PennsylvaniaAmish Research Clinic
Mar 6, 2023
Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists
Not yet recruiting
- Gastric Ultrasound
- +2 more
- Gastric Ultrasound Exam
- (no location specified)
Aug 15, 2023